Enhancement of intermittent androgen ablation by “off‐cycle” maintenance with finasteride in LNCaP prostate cancer xenograft model - Concepedia

Concepedia

Publication | Closed Access

Enhancement of intermittent androgen ablation by “off‐cycle” maintenance with finasteride in LNCaP prostate cancer xenograft model

34

Citations

28

References

2005

Year

Scott E. Eggener, Jeff A. Stern, Pankaj Jain, Shane Oram, Junkui Ai, Xiaoyan Cai, Kim Roehl, Zhou Wang

Abstract

IAA with finasteride provides the most favorable tumor growth kinetics and survival compared to both CAA and standard IAA.

References

	Year	Citations
The Influence of Finasteride on the Development of Prostate Cancer Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen, New England Journal of Medicine	2003	2.5K
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer Mary‐Ellen Taplin, Glenn J. Bubley, Todd D. Shuster, New England Journal of Medicine	1995	1.3K
A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens Jos Veldscholte, C. Ris-Stalpers, George G. J. M. Kuiper, Biochemical and Biophysical Research Communications Androgen ReceptorSignal TransductionMolecular PhysiologyHuman Incap CellsEndocrine Mechanism	1990	939
Tumor measurement in the nude mouse David Euhus, Charles Hudd, Marie C. LaRegina, Journal of Surgical Oncology	1986	607
National Practice Patterns and Time Trends in Androgen Ablation for Localized Prostate Cancer Matthew R. Cooperberg, Gary D. Grossfeld, Deborah P. Lubeck, JNCI Journal of the National Cancer Institute	2003	334
The Response of Metastatic Adenocarcinoma of the Prostate to Exogenous Testosterone Jackson E. Fowler, Willet F. Whitmore The Journal of Urology UrologyGenitourinary CancerExogenous TestosteroneMedicineTestosterone Withdrawal	1981	261
Androgen-repressed phenotype in human prostate cancer Hai Yen E. Zhau, Shi‐Ming Chang, Bao-Qi Chen, Proceedings of the National Academy of Sciences	1996	229
Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride. Yoshihisa Umekita, Richard A. Hiipakka, John M. Kokontis, Proceedings of the National Academy of Sciences	1996	195
Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model Naohide Sato, Martin Gleave, Nicholas Bruchovsky, The Journal of Steroid Biochemistry and Molecular Biology UrologyGenitourinary CancerHormonal ReceptorProstate-specific Antigen GeneEndocrinology	1996	187
Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat. A. Stuart Wright, Lynn N. Thomas, R.C. Douglas, Journal of Clinical Investigation SpermatogenesisCastrated RatNormal Prostate WeightPharmacotherapyProstate Cell Death	1996	135

Page 1